These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24637744)

  • 1. Proline modulates the Trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel D, L-proline transporter.
    Sayé M; Miranda MR; di Girolamo F; de los Milagros Cámara M; Pereira CA
    PLoS One; 2014; 9(3):e92028. PubMed ID: 24637744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
    Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter.
    Sayé M; Fargnoli L; Reigada C; Labadie GR; Pereira CA
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2913-2921. PubMed ID: 28844978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi Proline Transport Presents a Cell Density-dependent Regulation.
    Sayé M; Miranda MR; Reigada C; Pereira CA
    J Eukaryot Microbiol; 2016 Jul; 63(4):516-23. PubMed ID: 26750517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.
    Quebrada Palacio LP; González MN; Hernandez-Vasquez Y; Perrone AE; Parodi-Talice A; Bua J; Postan M
    PLoS One; 2018; 13(9):e0203462. PubMed ID: 30183775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele.
    Allaoui A; François C; Zemzoumi K; Guilvard E; Ouaissi A
    Mol Microbiol; 1999 Jun; 32(6):1273-86. PubMed ID: 10383767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
    Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
    PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma brucei eflornithine transporter AAT6 is a low-affinity low-selective transporter for neutral amino acids.
    Mathieu C; González Salgado A; Wirdnam C; Meier S; Grotemeyer MS; Inbar E; Mäser P; Zilberstein D; Sigel E; Bütikofer P; Rentsch D
    Biochem J; 2014 Oct; 463(1):9-18. PubMed ID: 24988048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine Analogues Impair Cell Proliferation, the Intracellular Cycle and Metacyclogenesis in
    Souza ROO; Crispim M; Silber AM; Damasceno FS
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32252252
    [No Abstract]   [Full Text] [Related]  

  • 10. Trypanosoma cruzi Polyamine Transporter: Its Role on Parasite Growth and Survival Under Stress Conditions.
    Reigada C; Sayé M; Vera EV; Balcazar D; Fraccaroli L; Carrillo C; Miranda MR; Pereira CA
    J Membr Biol; 2016 Aug; 249(4):475-81. PubMed ID: 26983938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
    Maya JD; Rodríguez A; Pino L; Pabón A; Ferreira J; Pavani M; Repetto Y; Morello A
    Biol Res; 2004; 37(1):61-9. PubMed ID: 15174306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldo-keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma cruzi.
    González L; García-Huertas P; Triana-Chávez O; García GA; Murta SMF; Mejía-Jaramillo AM
    Mol Microbiol; 2017 Dec; 106(5):704-718. PubMed ID: 28884498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of a proline analogue, L-thiazolidine-4-carboxylic acid (T4C), on Trypanosoma cruzi.
    Magdaleno A; Ahn IY; Paes LS; Silber AM
    PLoS One; 2009; 4(2):e4534. PubMed ID: 19229347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-scale metabolic models highlight stage-specific differences in essential metabolic pathways in Trypanosoma cruzi.
    Shiratsubaki IS; Fang X; Souza ROO; Palsson BO; Silber AM; Siqueira-Neto JL
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008728. PubMed ID: 33021977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current drug therapy and pharmaceutical challenges for Chagas disease.
    Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
    Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi.
    Damasceno FS; Barisón MJ; Pral EM; Paes LS; Silber AM
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2717. PubMed ID: 24587468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: death phenotypes induced by ortho-naphthoquinone substrates of the aldo-keto reductase (TcAKR). Role of this enzyme in the mechanism of action of β-lapachone.
    Garavaglia PA; Rubio MF; Laverrière M; Tasso LM; Fichera LE; Cannata JJB; García GA
    Parasitology; 2018 Aug; 145(9):1251-1259. PubMed ID: 29400267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.